Home/Investors/5AM Ventures

5AM Ventures

Biotech Investor · 8 portfolio companies

Portfolio

8

Focus Areas

13

Top Stage

Pre-clinical

Investment Focus

Oncology Solid Tumors Autoimmune Disorders Inflammatory Disorders Metabolic Nephrology Genetic Disorders Obesity Metabolic Diseases Neuroscience Immunology Respiratory Pulmonology

Portfolio Companies

Company	Stage	Valuation	Focus
Radionetics Oncology	Pre-clinical	—	Oncology, Solid Tumors
Lifordi Immunotherapeutics	Phase 1	—	Autoimmune Disorders, Inflammatory Disorders
PIC Therapeutics	Pre-clinical	—	Oncology, Metabolic
RareCyte	Commercial	—	Oncology
Renasant Bio	Pre-clinical	—	Nephrology, Genetic Disorders
ProLynx	Pre-clinical	—	Obesity, Metabolic Diseases
Nido Biosciences	preclinical	—	Neuroscience, Immunology
Alveus Therapeutics	preclinical	—	Respiratory, Pulmonology

Frequent Co-Investors

OrbiMed3 shared Atlas Venture2 shared Frazier Life Sciences1 shared DCVC Bio1 shared ARCH Venture Partners1 shared Alexandria Venture Investments1 shared Access Biotechnology1 shared F-Prime Capital1 shared